Seifert J K, Junginger T
Klinik und Poliklinik für Allgemein- und Abdominalchirurgie, Universitätskliniken, Johannes-Gutenberg-Universität, Mainz.
Langenbecks Arch Chir. 1996;381(4):187-200. doi: 10.1007/BF00571684.
Between September 1985 and December 1994, liver resections with curative intent were performed for liver metastases of colorectal primaries in 76 patients at the department for abdominal surgery of the university of Mainz. Perioperative morbidity and 30-day mortality rates were 30.3% and 6.6% respectively. The 3- and 5-year survival rate was 53% and 36% respectively. For patients with complete tumor removal (R0 resection), excluding perioperative mortality, the following factors were associated with more prolonged survival after hepatic resection in univariate analysis. N1 stage of the colorectal primary compared to N2 stage (in patients with positive mesenterial lymph nodes); diameter of the largest metastasis between 2.1 and 3.5 cm; postoperative normalized CEA level (in patients with CEA level elevated to more than 4 ng/dl preoperatively); and wedge resections compared to hemihepatectomies. Regarding disease-free survival, only N1 stage of the colorectal primary compared to N2 stage and diameter of the largest metastasis between 2.1 and 3.5 cm had a positive influence. In multivariate analysis, the diameter of the largest metastasis was the only factor associated with survival time, while disease-free survival was influenced by the largest diameter of the metastasis, patient sex and N stage of the colorectal primary. Whether adjuvant therapies (systemic or regional chemotherapy) after curative resection of colorectal liver metastases is associated with better survival times remains an open question. Some of the above-mentioned prognostic factors may be helpful in selecting patients for entry into adjuvant therapy protocols.
1985年9月至1994年12月期间,美因茨大学腹部外科为76例结直肠癌肝转移患者进行了旨在治愈的肝切除术。围手术期发病率和30天死亡率分别为30.3%和6.6%。3年和5年生存率分别为53%和36%。对于肿瘤完全切除(R0切除)的患者,排除围手术期死亡率,在单因素分析中,以下因素与肝切除术后生存期延长相关。与N2期相比,结直肠癌原发病灶的N1期(肠系膜淋巴结阳性患者);最大转移灶直径在2.1至3.5 cm之间;术后CEA水平正常化(术前CEA水平升高至4 ng/dl以上的患者);与半肝切除术相比的楔形切除术。关于无病生存期,只有与N2期相比的结直肠癌原发病灶的N1期以及最大转移灶直径在2.1至3.5 cm之间有积极影响。在多因素分析中,最大转移灶直径是与生存时间相关的唯一因素,而无病生存期受转移灶最大直径、患者性别和结直肠癌原发病灶的N分期影响。结直肠癌肝转移根治性切除术后辅助治疗(全身或区域化疗)是否与更好的生存时间相关仍是一个悬而未决的问题。上述一些预后因素可能有助于选择患者进入辅助治疗方案。